Alexandria Center for Life Science-NYC
The City created a partnership to build the 1 million square foot state-of-the-art research center and development campus to serve as the flagship location for future bioscience expansion in New York City. Phase 1 of the new science campus was completed, positioning NYC to be a leader in bioscience research and development.
Harlem Biospace (Hb)
The Bloomberg administration opened Harlem Biospace (Hb), a biotech incubator that provides up to 24 competitively-selected, early-stage life sciences companies access to affordable wet-lab, microbench space, specialized laboratory equipment, mentorship, business support and programming.
NYC Life Sciences Fund
The fund was established by the Bloomberg administration in partnership with academic institutions, industry leaders, top-tier investors and the philanthropic community to deploy a minimum of $100 million to early-stage life sciences companies with the goal of launching 15 to 20 breakthrough ventures by 2020.
Biotech Tax Credit
The Bloomberg administration created a $3 million refundable tax credit for facilities, operations, and training for small biotech companies.
BioBat at Brooklyn Army Terminal
Located within the Brooklyn Army Terminal, BioBat will ultimately provide 500,000 square feet of commercial biotech space.
The City provided support to build the Genome Center. The Center will have 130 genetic sequencing machines, more than any other similar facility in the region, and will help position New York City as a leader in genetic research.
Mount Sinai Institute of Technology
The City provided $5 million to help establish the Mount Sinai Institute of Technology (MSIT). The Institute’s goal is to transform biomedicine through the discovery, design, development and delivery of entrepreneurially-driven, technology-based solutions to critical unmet medical needs, particularly in the current era of healthcare reform.